This announcement is a separate document:
广誉远中药股份有限公司关于上海证券交易所对公司2023年年度报告信息披露监管工作函的回复公告
Guangyuyuan Chinese Herbal Medicine Co., Ltd.'s reply to the Shanghai Stock Exchange's regulatory work letter on the company's 2023 annual report information disclosure.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.